Replies to post #192 on BiondVax Pharmaceuticals Ltd (BVXV)

[midastouch017]

Last July, the company announced it had initiated a Phase 1 clinical trial of its RedeeFlu vaccine. FluGen said at the time that the study was aimed at evaluating the safety of the vaccine, as well as the antibody and T-cell responses in participating patients.

http://www.xconomy.com/wisconsin/2017/04/11/flugen-raises-2m-more-provides-update-on-phase-1-trial/#